301096 fundamentals

An in-depth look to HANGZHOU BIO-SINCE operating, investing, and financing activities

301096 free cash flow for Q1 25 is -110.62 M CNY. For 2024, 301096 free cash flow was -589.5 M CNY and operating cash flow was -194.4 M CNY.

Q3 '20

Q4 '20

Q1 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Cash from operating activities

Cash from investing activities

Cash from financing activities

Currency: CNY